Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00897637 · ClinicalTrials.gov registry record

Gene Expression Profiles to Categorize Wilms Tumors

A clinical trial of Recurrent Wilms Tumor and Other Childhood Kidney Tumors and Stage IV Wilms Tumor, sponsored by Children's Oncology Group.

Completed
Registry status
600
Enrollment target
2
Study locations

NCT00897637 is a study of Recurrent Wilms Tumor and Other Childhood Kidney Tumors and Stage IV Wilms Tumor that has completed, run by Children's Oncology Group. The registered enrollment target is 600 participants. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00897637, a study of Recurrent Wilms Tumor and Other Childhood Kidney Tumors and Stage IV Wilms Tumor, has completed, sponsored by Children's Oncology Group.

COMPLETED
Registry status
600 participants
Enrollment target
2
Study locations

Study Summary

This laboratory study is using gene expression profiling to identify different categories of Wilms tumors. Studying the genes expressed in samples of tumor tissue from patients with cancer may help doctors identify biomarkers related to cancer.

Interventions

  • OTHER laboratory biomarker analysis

Study Locations (2)

California

  • Children's Oncology Group - Arcadia

Florida

  • Saint Mary's Hospital - West Palm Beach

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2004-02

Sponsor

Children's Oncology Group

342 total trials

What the Registry Record Tells You About NCT00897637

The ClinicalTrials.gov registry entry for NCT00897637 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Recurrent Wilms Tumor and Other Childhood Kidney Tumors appearing as the primary indexed condition, and to 1 intervention - of which laboratory biomarker analysis is the first listed.

NCT00897637 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Florida.

Frequently Asked Questions

What is clinical trial NCT00897637 about?

NCT00897637 is a clinical study titled "Gene Expression Profiles to Categorize Wilms Tumors". This laboratory study is using gene expression profiling to identify different categories of Wilms tumors. Studying the genes expressed in samples of tumor tissue from patients with cancer may help doctors identify biomarkers related to cancer.

What is the current status of trial NCT00897637?

This trial is currently completed. The enrollment target is 600 participants. The study started on 2004-02.

What conditions does trial NCT00897637 study?

This clinical trial studies the following conditions: Recurrent Wilms Tumor and Other Childhood Kidney Tumors, Stage IV Wilms Tumor, Stage V Wilms Tumor, Stage I Wilms Tumor, Stage II Wilms Tumor.

What interventions are being tested in trial NCT00897637?

The interventions under investigation include: laboratory biomarker analysis (OTHER).

Who is sponsoring clinical trial NCT00897637?

This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00897637 being conducted?

This trial has 2 study locations across California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Recurrent Wilms Tumor and Other Childhood Kidney Tumors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.